Stay updated with breaking news from Tom Woiwode. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PHILADELPHIA, July 31, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS)
Versant Ventures-backed Belharra Therapeutics has launched with $130 million in funding and a partnership with Roche subsidiary Genentech. The startup’s technology analyzes proteins in the context of the entire cell, enabling it to discover molecules that bid to targets previously deemed undruggable.
VectivBio Holding AG , a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, announced today that Wouter Joustra was elected as a new... | December 12, 2022
GuruFocus Article or News written by Value_Insider and the topic is about:
VectivBio Announces Results of Extraordinary General Meeting-Wouter Joustra Elected to the Board of Directors - read this article along with other careers information, tips and advice on BioSpace